Published in Aust J Exp Biol Med Sci on December 01, 1980
Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A (1984) 1.74
Cytotoxic T cells both produce and respond to interleukin 2. J Exp Med (1984) 1.17
Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis. Infect Immun (1989) 0.99
Cloning and expression of the rat interleukin-3 gene. Nucleic Acids Res (1986) 0.99
Production of human and murine interleukin-2 by toxic shock syndrome toxin-1. Immunology (1986) 0.97
Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major. Infect Immun (1986) 0.92
Generation of interleukin-2-dependent T cell lines from synovial fluids in rheumatoid arthritis. Clin Exp Immunol (1984) 0.83
Production of lymphocyte activating factor in vivo. Immunology (1983) 0.82
T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction. Proc Natl Acad Sci U S A (1986) 0.77
Traffic and proliferative responses of recirculating lymphocytes in fetal calves. Immunology (1988) 0.77
Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses. J Virol (1985) 0.75
T-cell repopulation following neonatal injection of non-obese diabetic (NOD) mice with anti-T-cell antibodies. Immunology (1992) 0.75
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
Secretion of plasminogen activator by stimulated macrophages. J Exp Med (1974) 8.82
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Actinomycin and nucleic acid function. Prog Nucleic Acid Res Mol Biol (1964) 5.00
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
Base specificity in the interaction of polynucleotides with antibiotic drugs. Science (1965) 3.72
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. J Biol Chem (1969) 3.39
The human tissue plasminogen activator gene. J Biol Chem (1986) 3.35
Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J Biol Chem (1974) 2.89
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
Antibodies to plasminogen activator inhibit human tumor metastasis. Cell (1983) 2.82
Replication and inheritance of mitochondrial DNA. Proc Natl Acad Sci U S A (1966) 2.72
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med (1977) 2.60
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell (1977) 2.47
A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci (1975) 2.33
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem (1985) 2.14
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell (1979) 2.13
Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med (1977) 2.00
A proenzyme form of human urokinase. J Biol Chem (1982) 1.98
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Effect of organ culture on the survival of thyroid allografts in mice. Transplantation (1976) 1.83
Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80
Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem (1969) 1.79
Thyroid allograft immunogenicity is reduced after a period in organ culture. Science (1975) 1.77
Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell (1983) 1.76
Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev (1980) 1.76
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Structure and activity of acetylcholine. Nature (1970) 1.75
Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun (1990) 1.74
The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc Natl Acad Sci U S A (1967) 1.65
Current status of immunological adjuvants. Annu Rev Immunol (1986) 1.65
Prospective study of manikin-only versus manikin and human subject endotracheal intubation training of paramedics. Ann Emerg Med (1991) 1.63
Clinical performance of a laser fluorescence device for detection of occlusal caries lesions. Eur J Oral Sci (2001) 1.62
Performance and reproducibility of a laser fluorescence system for detection of occlusal caries in vitro. Caries Res (1999) 1.62
Inhibition of T-cell activity by cyclosporin A. Scand J Immunol (1981) 1.61
Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids. J Exp Med (1976) 1.60
The origin and mechanism of the allograft reaction. Immunol Rev (1977) 1.60
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice. J Exp Med (1978) 1.60
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. J Exp Med (1981) 1.57
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun (1993) 1.50
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Reactions of the graft versus host (GVH) type. Aust J Exp Biol Med Sci (1969) 1.49
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Malarial immunodepression in vitro: adherent spleen cells are functionally defective as accessory cells in the response to horse erythrocytes. Eur J Immunol (1976) 1.47
Ammonium ions as the source of nitrogen for tryptophan biosynthesis in whole cells of Escherichia coli. Biochim Biophys Acta (1967) 1.46
cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucleic Acids Res (1984) 1.43
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Antisense transcription: a critical look in both directions. Cell Mol Life Sci (2009) 1.42
Gene expression and cAMP. Proc Natl Acad Sci U S A (1985) 1.41
Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet (1994) 1.40
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol (1994) 1.39
Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A (1977) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Acro-renal-ocular syndrome: expansion of the phenotype. Clin Dysmorphol (1998) 1.38
Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature (1974) 1.37
Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol (2001) 1.34
Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature (1979) 1.34
Strategies for the treatment of sepsis. N Engl J Med (1997) 1.33
Experimental model for quantitative study of metastasis. Cancer Res (1980) 1.32
The Th1/Th2 balance in autoimmunity. Curr Opin Immunol (1995) 1.32
Exonuclease VI, a new nuclease activity associated with E. coli DNA polymerase. Proc Natl Acad Sci U S A (1968) 1.32
Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut (2010) 1.31
Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell (1983) 1.31
RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes. J Exp Med (1979) 1.30
Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate. J Clin Microbiol (1985) 1.30
Selective lysis of cells transformed by Rous Sarcoma virus. Virology (1971) 1.29
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
SEPARATION OF THE BIOSYNTHESIS OF THE ANTIBIOTIC POLYPEPTIDE TYROCIDINE FROM PROTEIN BIOSYNTHESIS. Proc Natl Acad Sci U S A (1963) 1.28
Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells. Cell (1975) 1.25
Neutralization of bacterial lipopolysaccharides by human plasma. J Clin Microbiol (1985) 1.25
The role of the lymphatic system and lymphoid cells in the establishment of immunological memory. Aust J Exp Biol Med Sci (1970) 1.24
Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator. Blood Cells (1978) 1.23
Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23. Blood (1984) 1.21
Metabolism of acetylcholine receptor in chick embryo muscle cells: effects of RSV and PMA. Cell (1978) 1.20
The enchancement of virus infectivity by antibody. Virology (1967) 1.19
Muscle differentiation in cell culture. Effects of nucleoside inhibitors and Rous sarcoma virus. J Biol Chem (1972) 1.19
Plasminogen activator in the bursa of Fabricius: correlations with morphogenetic remodeling and cell migrations. Cell (1981) 1.18
Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent. Diabetes (1987) 1.17
Neutralization and lipoprotein binding of lipopolysaccharides in tolerant rabbit serum. J Infect Dis (1986) 1.17
Cytotoxic T cells both produce and respond to interleukin 2. J Exp Med (1984) 1.17
Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. J Urol (2001) 1.16
Plasminogen activator: induction of synthesis by DNA damage. Cell (1980) 1.15
Reversal of diabetes by allogenic islet transplantation without immunosuppression. Aust J Exp Biol Med Sci (1980) 1.15
Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production. Cancer Res (1976) 1.14
Degradation of ribonucleic acid in mouse fibroblasts treated with actinomycin. J Cell Biol (1965) 1.14
Plasminogen activator of islets of Langerhans: modulation by glucose and correlation with insulin production. Proc Natl Acad Sci U S A (1980) 1.14
Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell (1978) 1.14
Conformational properties of polyformycin: a polyribonucleotide with individual residues in the syn conformation. Proc Natl Acad Sci U S A (1968) 1.12
Studies of Rous sarcoma virus. Effects of nucleoside analogues on virus synthesis. J Biol Chem (1973) 1.11